Association between IL17A/IL17RA gene polymorphisms and susceptibility to alopecia areata in the Korean population

Annals of Dermatology

Volumn 24, Issue 1, 2012, Pages 61-65

  Lew, Bark Lynn ^a   Cho, Hee Ryung ^a   Haw, Sik ^a   Kim, Hwi Jun ^a   Chung, Joo Ho ^b   Sim, Woo Young ^a  

^a Kyung Hee University College of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

Alopecia areata; Interleukin 17 receptors A; Interleukin 17A; Single nucleotide polymorphism

Indexed keywords

EID: 84863151367     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2012.24.1.61     Document Type: Article

References (25)

1. Wiesner-Menzel L, Happle R. Intrabulbar and peribulbar accumulation of dendritic OKT 6-positive cells in alopecia areata. Arch Dermatol Res 1984;276:333-334. (Pubitemid 14088195)
2. McElwee KJ, Yu M, Park SW, Ross EK, Finner A, Shapiro J. What can we learn from animal models of Alopecia areata? Dermatology 2005;211:47-53. (Pubitemid 40911564)
3. Gilhar A, Kalish RS. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 2006;5:64-69. (Pubitemid 41759444)
4. Shapiro J. Topical immunotherapy in the treatment of chronic severe alopecia areata. Dermatol Clin 1993;11:611-617. (Pubitemid 23229741)
5. Yoshino T, Asada H, Ando Y, Fujii H, Yamaguchi Y, Yoshikawa K, et al. Impaired responses of peripheral blood mononuclear cells to T-cell stimulants in alopecia areata patients with a poor response to topical immunotherapy. Br J Dermatol 2001;145:415-421. (Pubitemid 32953697)
6. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010;62:177-188.
7. Kalish RS, Gilhar A. Alopecia areata: autoimmunity-the evidence is compelling. J Investig Dermatol Symp Proc 2003;8:164-167. (Pubitemid 37222823)
8. Yu JJ, Gaffen SL. Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci 2008;13:170-177. (Pubitemid 351594768)
9. Ghilardi N, Ouyang W. Targeting the development and effector functions of TH17 cells. Semin Immunol 2007;19:383-393.
10. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003;278:1910-1914. (Pubitemid 36801431)
11. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201:233-240. (Pubitemid 40189432)
12. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6:1123-1132. (Pubitemid 41541790)
13. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441:235-238.
14. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006;24:179-189. (Pubitemid 43214587)
15. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995;3:811-821. (Pubitemid 26091152)
16. Solé X, Guinó E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006;22:1928-1929. (Pubitemid 44283043)
17. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265. (Pubitemid 40202029)
18. Jung MY, Kim BS, Kim YJ, Koh IS, Chung JH. Assessment of relationship between Fyn-related kinase gene polymorphisms and overweight/obesity in Korean population. Korean J Physiol Pharmacol 2008;12:83-87. (Pubitemid 351736664)
19. Hordinsky M, Ericson M. Autoimmunity: alopecia areata. J Investig Dermatol Symp Proc 2004;9:73-78. (Pubitemid 38100508)
20. McMichael AJ. The genetic epidemiol autoimmune pathogenesis alopecia areata. J Eur Acad Dermatol Venereol 1997;9:36-43. (Pubitemid 27362372)
21. McDonagh AJ, Tazi-Ahnini R. Epidemiology and genetics of alopecia areata. Clin Exp Dermatol 2002;27:405-409.
22. Tazi-Ahnini R, Cork MJ, Gawkrodger DJ, Birch MP, Wengraf D, McDonagh AJ, et al. Role of the autoimmune regulator (AIRE) gene in alopecia areata: strong association of a potentially functional AIRE polymorphism with alopecia universalis. Tissue Antigens 2002;60:489-495. (Pubitemid 36177271)
23. Tazi-Ahnini R, Cork MJ, Wengraf D, Wilson AG, Gawkrodger DJ, Birch MP, et al. Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata. Hum Genet 2003;112:400-403. (Pubitemid 36869068)
24. Tazi-Ahnini R, Cox A, McDonagh AJ, Nicklin MJ, di Giovine FS, Timms JM, et al. Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction. Eur J Immunogenet 2002;29:25-30. (Pubitemid 34146656)
25. Shimizu T, Hizawa N, Honda A, Zhao Y, Abe R, Watanabe H, et al. Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata. Genes Immun 2005;6:285-289. (Pubitemid 40903400)